Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-15

Srikanth Vallurupalli

High Impact

Associate Professor

Also affiliated: Rush University Medical Center (2024); MedStar Washington Hospital Center (2013); University of Kentucky (1995–2018); University of Kansas (2013); Emory University (2013); University of Illinois Urbana-Champaign (2007–2009); Wayne State University (2013); Southern Illinois University School of Medicine (2009–2011); University of Arkansas Medical Center (2016–2025); Truman Medical Center (2022); Staten Island University Hospital (2013); The University of Kansas Health System (2013); Henry Ford Hospital (2021); Central Arkansas Veterans Healthcare System (2014–2025); University of Kansas Medical Center (2013); Minneapolis Heart Institute Foundation (2018); Association Clinique et Thérapeutique Infantile du Val de Marne (2023); Novant Health Forsyth Medical Center (2024); Arkansas Department of Agriculture (2020); Drexel University (2013); University of Missouri–Kansas City (2021)

Faculty Researcher

Internal Med, College of Medicine

22 h-index 208 pubs 2,566 cited

  • Humans
  • Male
  • Female
  • Middle Aged
  • Treatment Outcome
  • Aged
  • Coronary Artery Disease
  • Risk Factors
  • Retrospective Studies
  • Myocardial Infarction
  • Percutaneous Coronary Intervention
  • Echocardiography
  • Stents
  • Predictive Value of Tests
  • Adult

Biography and Research Information

OverviewAI-generated summary

Srikanth Vallurupalli, MD, is an Associate Professor in the Department of Internal Medicine, Division of Cardiology, at the University of Arkansas for Medical Sciences (UAMS). His clinical practice includes serving as a staff cardiologist at the Central Arkansas Veterans Health Care System (CAVHS).

Dr. Vallurupalli's research interests include the management of valvular heart disease and left ventricular thrombus. He has contributed to multiple scientific statements and meta-analyses, focusing on cardiovascular conditions such as acute heart failure, myocardial ischemia, and coronary artery disease. His work also extends to investigating the efficacy and safety of various therapeutic agents, including sodium-glucose cotransporter 2 inhibitors and ezetimibe. He has led a research group and collaborates with several colleagues at UAMS, including Fuad Habash, Hakan Paydak, Subodh Devabhaktuni, and Barry F. Uretsky.

With 207 publications and an h-index of 22, Dr. Vallurupalli has received recognition as a highly cited researcher. His scholarly activities encompass a broad range of cardiovascular topics, supported by his advanced training in echocardiography.

Research Overview

Srikanth Vallurupalli MD is an Assistant Professor of Medicine in the Division of Cardiology, College of Medicine at the University of Arkansas for Medical Sciences (UAMS) and a staff cardiologist at the Central Arkansas Veterans Health Care System(CAVHS).Dr. Vallurupalli attended medical school at the Jawaharlal Institute of Post Graduate Medical education and Research(JIPMER) in Pondicherry, India. He completed his internal medicine residency and served as a chief medical resident at the University of Illinois at Urbana Champaign. He then worked an as Assistant Professor of General Internal Medicine at the Southern Illinois University in Springfield, IL before moving to Little Rock to complete his cardiovascular diseases fellowship at UAMS. He received advanced training in echocardiography (level 3) and has special interest in the management of valvular heart disease.

Metrics

  • h-index: 22
  • Publications: 208
  • Citations: 2,566

Selected Publications

  • Abstract Wed134: Comparison of classic vs newer classification of Doppler wave forms of lower extremity arteries in diagnosis of obstructive peripheral arterial disease (2026)
  • Bridging the Coverage Gap: State Medicaid Limitations for Cardiac Rehabilitation Programs and the Risk to Disadvantaged Communities (2026)
  • Characterization of Human Aortic Valve Cells isolated from Calcified Aortic Valve Replacement Explants: Implications for Calcific Aortic Valve Disease Research (2026)
  • 26-A-9693-ACC PREDICTION OF 1-YEAR MAJOR ADVERSE CARDIAC EVENTS IN CAR-T RECIPIENTS USING RISK SCORE MODELING: EXPANDED WHOLE-COHORT ANALYSIS (2026)
  • 26-A-11133-ACC CYTOKINE RELEASE SYNDROME-GUIDED RISK MODELS REDEFINE CARDIOTOXICITY SURVEILLANCE: OPTIMIZING DETECTION OF CANCER THERAPY-RELATED CARDIAC DYSFUNCTION AND ADVERSE CARDIOVASCULAR EVENTS AFTER CAR-T THERAPY (2026)
  • 26-A-17971-ACC WHEN NORMAL ISN’T SAFE, PRESERVED PERFORMANCE, HIGHER RISK: ECHO-DERIVED FRANK-STARLING PROFILING IN POST-TIPS HEART FAILURE — PARADOXICAL ECHOCARDIOGRAPHIC PREDICTORS OF CHF READMISSION, DIURETIC ESCALATION, AND VOLUME OVERLOAD IN A PRELOAD-SENSITIVE STATE (2026)
  • 26-CCC-10096-ACC CHEMOTHERAPY-INDUCED CARDIOTOXICITY VS LEFT BUNDLE BRANCH BLOCK CARDIOMYOPATHY: A DIAGNOSTIC AND MANAGEMENT CHALLENGE (2026)
  • Incidence, predictors, and pacemaker implantation rates after high-grade atrioventricular block following transcatheter tricuspid valve replacement: a real-world analysis (2026)
  • Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis (2025)
    Cureus DOI OpenAlex
  • Late-Onset Pericardial Effusion and Device Extrusion After Left Atrial Appendage Occluder Implantation (2025)
    JACC Case Reports DOI OpenAlex
  • Right Ventricular Outflow Tract Velocity Time Interval: An Invaluable Yet Forgotten Echocardiographic Variable (2025)
    Echocardiography DOI OpenAlex
  • Diagnostic and prognostic utility of fractional flow reserve for in-stent restenosis (2025)
    Cardiovascular revascularization medicine 2 citations DOI OpenAlex
  • HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE (2025)
    Journal of the American College of Cardiology DOI OpenAlex
  • PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY (2025)
    Journal of the American College of Cardiology DOI OpenAlex
  • POTENTIAL INCREMENTAL VALUE OF ROUTINE ECHOCARDIOGRAPHY IN MULTIPLE MYELOMA: RESULTS FROM ARETROSPECTIVE NON-DRIVEN IMAGING DATA ANALYSIS DURING DIFFERENT STAGES OF TREATMENT (2025)
    Journal of the American College of Cardiology DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

  • COVID-19 PREVENT (Partnership for Rapid Engagement to enhance Vaccine uptake for Everyone: Neighbors working Together) Project NIH/Nat. Heart, Lung & Blood Institute via Westat Principal Investigator

Collaboration Network

150 Collaborators 72 Institutions 7 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics